Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Br J Haematol

Retrieve available abstracts of 311 articles:
HTML format

Single Articles

    March 2023
  1. IBEMERE SO, Oyedeji CI, Preiss L, Van Althuis LE, et al
    Characterising the prevalence of overweight and obese status among adults with sickle cell disease.
    Br J Haematol. 2023;200:633-642.
    PubMed     Abstract available

  2. JOSEPH L, Corbasson A, Manceau S, Khimoud D, et al
    Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease.
    Br J Haematol. 2023;200:563-567.
    PubMed     Abstract available

  3. TSITSIKAS DA, Rowe S, Bosch A, Hui C, et al
    Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease.
    Br J Haematol. 2023;200:e50-e52.

  4. MCKEAGUE S, Peake N, Lovelock D, Chow J, et al
    Acquired HbH disease diagnosed by HbA1c capillary electrophoresis.
    Br J Haematol. 2023;200:687.

  5. KOEHL B, Claude L, Reminy K, Tarer V, et al
    Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait.
    Br J Haematol. 2023;200:812-820.
    PubMed     Abstract available

    February 2023
  6. POUTREL S, Boisson C, Nader E, Renoux C, et al
    Clinical severity and blood rheology in patients with sickle cell anaemia and co-existing autoimmune disease.
    Br J Haematol. 2023;200:e28-e31.

  7. AGUWA CJ, Cannon AD, Casella JF, Shapiro BK, et al
    Current developmental screening practices in young children with sickle cell disease.
    Br J Haematol. 2023;200:377-380.
    PubMed     Abstract available

  8. HEITZER AM, Schreiber JE, Yuan X, Wang F, et al
    Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controls.
    Br J Haematol. 2023;200:358-366.
    PubMed     Abstract available

  9. HU J, Gong S, Chen K, Yang R, et al
    Haploidentical transplant for paediatric patients with severe thalassaemia using post-transplant cyclophosphamide and methotrexate: A prospectively registered multicentre trial from the Bone Marrow Failure Working Group of Hunan Province, China.
    Br J Haematol. 2023;200:329-337.
    PubMed     Abstract available

  10. SIRIWORADETKUN S, Thiengtavor C, Thubthed R, Paiboonsukwong K, et al
    A comprehensive study of immune function and immunophenotyping of white blood cells from beta-thalassaemia/HbE patients on hydroxyurea supports the safety of the drug.
    Br J Haematol. 2023;200:367-376.
    PubMed     Abstract available

  11. RICCHI P
    Liver fibrosis in young patients with transfusion-dependent thalassaemia (TDT), understanding the role of steatosis.
    Br J Haematol. 2023;200:399-400.
    PubMed     Abstract available

  12. PADENIYA P, Ediriweera D, De Silva AP, Niriella M, et al
    The association between steatosis and liver damage in transfusion-dependent beta thalassaemia patients.
    Br J Haematol. 2023;200:517-523.
    PubMed     Abstract available

    January 2023
  13. NGUYEN PC, Tiong IS, Westerman DA, Blombery P, et al
    A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemia.
    Br J Haematol. 2023;200:e13-e16.

  14. ZHU D, Liang G, Zhang Y, Wei X, et al
    Identification of haemolytic anaemia caused by glucose phosphate isomerase deficiency in a thalassaemia-endemic region: Correction of misdiagnosis and consideration of the cause of misdiagnosis.
    Br J Haematol. 2023;200:e8-e12.

    Immunomodulation for early-onset haemolytic disease of the fetus/newborn: Can we delay the need for intrauterine transfusions?
    Br J Haematol. 2023;200:11-12.
    PubMed     Abstract available

  16. WILSON J
    Rasburicase-induced methaemoglobinaemia and catastrophic oxidative haemolysis in undiagnosed G6PD deficiency.
    Br J Haematol. 2023;200:7.

  17. VAN DIJK MJ, van Oirschot BA, Stam-Slob MC, Waanders E, et al
    Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review.
    Br J Haematol. 2023;200:249-255.
    PubMed     Abstract available

    December 2022
  18. ZAMAN BA, Rasool SO, Abdo JM
    The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
    Br J Haematol. 2022 Dec 19. doi: 10.1111/bjh.18619.
    PubMed     Abstract available

  19. LI M, Liu L, Ding B, Song X, et al
    Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib.
    Br J Haematol. 2022;199:e37-e42.

  20. WINER JC, Yee ME, Ataga KI, Lebensburger JD, et al
    Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System study.
    Br J Haematol. 2022;199:e43-e47.

  21. DE LA IGLESIA INIGO S, Navarrete Bullon L, Stuckey R, Veiga Vaz A, et al
    Cauda equina syndrome secondary to extramedullary erythropoiesis in a transfusion-dependent thalassemia patient following treatment with luspatercept: A case report.
    Br J Haematol. 2022;199:e30-e33.

  22. RAJPUT RV, Ma X, Boswell KL, Gaudinski M, et al
    Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
    Br J Haematol. 2022;199:679-687.
    PubMed     Abstract available

  23. CONNELLY JA, Savani BN
    Irradiation-free, T-cell replete haploidentical transplant for Fanconi anaemia, weighing the benefits.
    Br J Haematol. 2022;199:639-641.
    PubMed     Abstract available

  24. VIAL Y, Lainey E, Leblanc T, Baudouin V, et al
    De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.
    Br J Haematol. 2022;199:739-743.
    PubMed     Abstract available

    November 2022
  25. AMPOMAH MA, Drake JA, Anum A, Amponsah B, et al
    A case-control and seven-year longitudinal neurocognitive study of adults with sickle cell disease in Ghana.
    Br J Haematol. 2022;199:411-426.
    PubMed     Abstract available

  26. XU L, Lu Y, Hu S, Li C, et al
    Unmanipulated haploidentical haematopoietic cell transplantation with radiation-free conditioning in Fanconi anaemia: A retrospective analysis from the Chinese Blood and Marrow Transplantation Registry Group.
    Br J Haematol. 2022;199:401-410.
    PubMed     Abstract available

  27. HAN J, Zhang X, Molokie RE, Njoku FU, et al
    COVID-19 vaccination status and disease burden in patients with sickle cell disease.
    Br J Haematol. 2022;199:e21-e24.

  28. OGUNSILE FJ, Stewart KJ, Kanter J, Lanzkron SM, et al
    An evaluation of cardiopulmonary endurance and muscular strength in adults living with sickle cell disease.
    Br J Haematol. 2022;199:597-602.
    PubMed     Abstract available

  29. RODRIGUEZ CORTE J, Candal-Pedreira C, Ruano-Ravina A, Perez-Rios M, et al
    Home-based blood transfusion therapy: A systematic review.
    Br J Haematol. 2022;199:496-506.
    PubMed     Abstract available

    October 2022
  30. TORTI L
    Life beyond alpha-thalassaemia: We are moving forward.
    Br J Haematol. 2022;199:11-13.
    PubMed     Abstract available

  31. PAALVAST Y, Moazzen S, Sweegers M, Hogema B, et al
    A computational model for prediction of ferritin and haemoglobin levels in blood donors.
    Br J Haematol. 2022;199:143-152.
    PubMed     Abstract available

  32. CONRAN N, de Alvarenga Maximo C, Oliveira T, Fertrin KY, et al
    Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study.
    Br J Haematol. 2022;199:153-157.

  33. AKE-SITTIPAISARN S, Sirichotiyakul S, Srisupundit K, Luewan S, et al
    Outcomes of pregnancies complicated by haemoglobin H-constant spring and deletional haemoglobin H disease: A retrospective cohort study.
    Br J Haematol. 2022;199:122-129.
    PubMed     Abstract available

  34. EYSSETTE-GUERREAU S, Khimoud D, Michaux K, Odievre MH, et al
    Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination.
    Br J Haematol. 2022;199:e8-e11.

  35. ESPERTI S, Boisson C, Robert M, Nader E, et al
    Does G6PD deficiency cause further damage to red blood cells of patients with sickle cell anaemia?
    Br J Haematol. 2022;199:289-291.

  36. QUARELLO P, Ramenghi U, Fagioli F
    Diamond-Blackfan anaemia with iron overload: A serious issue.
    Br J Haematol. 2022;199:171-172.
    PubMed     Abstract available

  37. CHURCHILL D, Ali H, Moussa M, Donohue C, et al
    Maternal iron deficiency anaemia in pregnancy: Lessons from a national audit.
    Br J Haematol. 2022;199:277-284.
    PubMed     Abstract available

  38. LECORNEC N, Castex MP, Reguerre Y, Moreau P, et al
    Agranulocytosis in patients with Diamond-Blackfan anaemia (DBA) treated with deferiprone for post-transfusion iron overload: A retrospective study of the French DBA cohort.
    Br J Haematol. 2022;199:285-288.

    September 2022
  39. WULFTANGE WJ, Kucukal E, Man Y, An R, et al
    Antithrombin-III mitigates thrombin-mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow.
    Br J Haematol. 2022;198:893-902.
    PubMed     Abstract available

  40. CORNELISSEN HM, Musekwa EM, Glashoff RH, Esser M, et al
    Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.
    Br J Haematol. 2022;198:875-886.
    PubMed     Abstract available

  41. ALIBERTI L, Gagliardi I, Gamberini MR, Ziggiotto A, et al
    Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.
    Br J Haematol. 2022;198:903-911.
    PubMed     Abstract available

  42. ARITA K, Murakami J, Iwaki N, Hosono N, et al
    An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.
    Br J Haematol. 2022;198:e75-e77.

  43. PATEL NG, Young D, Numan Y, Bhasin A, et al
    The utility of peripheral blood film and haemolysis markers in evaluation of haemolytic anaemia at a tertiary care hospital.
    Br J Haematol. 2022;198:927-929.

  44. VERCELLATI C, Zaninoni A, Marcello AP, Fermo E, et al
    Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 years.
    Br J Haematol. 2022;198:912-915.
    PubMed     Abstract available

  45. TANTRAVAHI SK, Huber BD, Vagher J, Maese L, et al
    Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.
    Br J Haematol. 2022;198:e78-e81.

  46. SONGDEJ D, Kadegasem P, Tangbubpha N, Sasanakul W, et al
    Whole-exome sequencing uncovered genetic diagnosis of severe inherited haemolytic anaemia: Correlation with clinical phenotypes.
    Br J Haematol. 2022;198:1051-1064.
    PubMed     Abstract available

    August 2022
  47. WILSON J
    Unlikely bedfellows - Sickle cells with malaria parasites.
    Br J Haematol. 2022 Aug 12. doi: 10.1111/bjh.18412.

  48. MORICONI C, Dzieciatkowska M, Roy M, D'Alessandro A, et al
    Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
    Br J Haematol. 2022;198:574-586.
    PubMed     Abstract available

  49. ROY NBA, Da Costa L, Russo R, Bianchi P, et al
    The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper.
    Br J Haematol. 2022;198:459-477.

  50. NISHIMURA JI, Usuki K, Ramos J, Ichikawa S, et al
    Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
    Br J Haematol. 2022;198:e46-e50.

  51. GAARTMAN AE, Strijdhorst A, van Es N, Tang MW, et al
    Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait.
    Br J Haematol. 2022;198:e42-e45.

  52. GREEN NS, Van Doren L, Licursi M, Billings DD, et al
    Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City.
    Br J Haematol. 2022;198:680-683.

  53. SHARMA A, Leonard A, West K, Gossett JM, et al
    Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.
    Br J Haematol. 2022;198:740-744.
    PubMed     Abstract available

  54. URSULE-DUFAIT C, Bengoufa D, Theodorou I, Villesuzanne C, et al
    Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease.
    Br J Haematol. 2022;198:e67-e70.

  55. OGBENNA AA, Akinsete AM, Kalejaiye OO, Matthew OK, et al
    Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy.
    Br J Haematol. 2022;198:745-752.
    PubMed     Abstract available

  56. GELBENEGGER G, Jaeger U, Fillitz M, D'Sa S, et al
    Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.
    Br J Haematol. 2022;198:e59-e62.

    July 2022
  57. SCOTT C, Bartolovic K, Clark SA, Waithe D, et al
    Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level.
    Br J Haematol. 2022;198:e10-e14.

  58. COOPER-SOOD JB, Hagar W, Marsh A, Hoppe C, et al
    Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.
    Br J Haematol. 2022;198:207-209.

  59. BUESCHE G, Teoman H, Schneider RK, Ribezzo F, et al
    Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche.
    Br J Haematol. 2022;198:114-130.
    PubMed     Abstract available

  60. CAUGHEY MC, Derebail VK, Carden MA, Novelli EM, et al
    Prevalence and outcomes of dehydration in adults with sickle cell trait: the Atherosclerosis Risk in Communities (ARIC) study.
    Br J Haematol. 2022;198:397-400.

  61. GUO JJ, Cao L, Zhu HY, Miao Y, et al
    T-cell large granular lymphocytic leukaemia with atypical immunophenotypes: A single-centre retrospective analysis of 17 cases.
    Br J Haematol. 2022;198:e18-e22.

    Acute haemolysis following COVID-19 vaccination in a thalassaemic patient with G6PD deficiency.
    Br J Haematol. 2022;198:221.

  63. EARLY ML, Linton E, Bosch A, Campbell T, et al
    The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains.
    Br J Haematol. 2022;198:382-390.
    PubMed     Abstract available

    June 2022
  64. DELAPORTA P, Terpos E, Solomou EE, Gumeni S, et al
    Immune response and adverse events after vaccination against SARS-CoV-2 in adult patients with transfusion-dependent thalassaemia.
    Br J Haematol. 2022;197:576-579.
    PubMed     Abstract available

  65. PICCIN A, O'Connor-Byrne N, Daves M, Lynch K, et al
    Autoimmune disease and sickle cell anaemia: 'Intersecting pathways and differential diagnosis'.
    Br J Haematol. 2022;197:518-528.
    PubMed     Abstract available

  66. HAN J, Molokie RE, Hussain F, Njoku F, et al
    Voxelotor and albuminuria in adults with sickle cell anaemia.
    Br J Haematol. 2022;197:e63-e64.

  67. SHEEHAN VA, van Beers EJ, Connes P, van Wijk R, et al
    Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
    Br J Haematol. 2022;197:e61-e62.

  68. JOLY P, Boisson C, Renoux C, Caillat N, et al
    Determinants of the point of sickling measured by oxygen gradient ektacytometry in sickle cell anaemia.
    Br J Haematol. 2022;197:e56-e58.

  69. NARDO-MARINO A, Petersen J, Brewin JN, Birgens H, et al
    Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
    Br J Haematol. 2022;197:609-617.
    PubMed     Abstract available

  70. MARSHALL WH 5TH, Cleary EM, Della-Moretta S, Li R, et al
    Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease.
    Br J Haematol. 2022;197:795-801.

    May 2022
  71. AMID A, Barrowman N, Odame I, Kirby-Allen M, et al
    Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and "functional" haemoglobin level.
    Br J Haematol. 2022;197:373-376.
    PubMed     Abstract available

  72. LONGORIA JN, Heitzer AM, Hankins JS, Trpchevska A, et al
    Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations.
    Br J Haematol. 2022;197:260-270.
    PubMed     Abstract available

  73. BAIN BJ, Littlewood T, Rees DC
    What does the term 'sickle cell disease' mean?
    Br J Haematol. 2022;197:381-382.

  74. ALTER BP, Giri N, McReynolds LJ, Altintas B, et al
    Fanconi anaemia: A syndrome with distinct subgroups.
    Br J Haematol. 2022;197:467-474.
    PubMed     Abstract available

  75. VORA SM, Boyd S, Denny N, Jackson E, et al
    Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor.
    Br J Haematol. 2022;197:502-504.

    April 2022
  76. TANIGUCHI T, Nakayama S, Tanaka H, Rai S, et al
    Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells.
    Br J Haematol. 2022 Apr 22. doi: 10.1111/bjh.18208.
    PubMed     Abstract available

  77. SUN Y, Habara A, Le CQ, Nguyen N, et al
    Pharmacologic induction of PGC-1alpha stimulates fetal haemoglobin gene expression.
    Br J Haematol. 2022;197:97-109.
    PubMed     Abstract available

  78. RIEU JB, Largeaud L, Da Costa L, Cougoul P, et al
    Unexplained iron overload with haemolytic anaemia should prompt looking for morphological changes in erythroid precursors.
    Br J Haematol. 2022;197:132.

  79. ROSS DM
    Iron chelation for myelofibrosis-related anaemia during treatment with a Janus kinase inhibitor.
    Br J Haematol. 2022;197:135-136.

  80. GARG M, Agarwal S, Altohami M
    A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report.
    Br J Haematol. 2022;197:e28-e31.

  81. BATISTA THC, Santana RM, Sobreira MJ, Arcanjo GS, et al
    Up-regulation of miR-130a is related to leg ulcers in sickle cell anaemia.
    Br J Haematol. 2022;197:e16-e18.

  82. TORRES LS, Teles LIM, Shaul ME, Fridlender ZG, et al
    Accelerated low-density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology.
    Br J Haematol. 2022;197:232-235.

    March 2022
  83. MIODOWNIK H, Curtis SA, Olivia Ogu U, Bradford C, et al
    Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease.
    Br J Haematol. 2022;196:e41-e44.

  84. CECCHI N, Giannotta JA, Barcellini W, Fattizzo B, et al
    A case of severe aplastic anaemia after SARS-CoV-2 vaccination.
    Br J Haematol. 2022;196:1334-1336.

  85. CONSTANTINOU V, Papayanni PG, Mallouri D, Batsis I, et al
    Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent beta-thalassaemia of a severe genotype.
    Br J Haematol. 2022;196:1401-1404.

  86. CHARNAY T, Cerino M, Gonnet K, Bonello-Palot N, et al
    A novel SUPT5H variant associated with a beta-thalassaemia trait.
    Br J Haematol. 2022;196:e70-e71.

  87. TAMURA S, Hori Y, Hiroi T, Morimoto M, et al
    Pegcetacoplan for refractory paroxysmal nocturnal haemoglobinuria associated with the C5 genetic variant.
    Br J Haematol. 2022;196:e57-e60.

    February 2022
  88. RUND D
    Laboratory diagnosis of iron deficiency: look out for the 'PITTs'.
    Br J Haematol. 2022;196:464-465.

  89. XU LP, Yu Y, Cheng YF, Zhang YY, et al
    Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation.
    Br J Haematol. 2022;196:735-742.
    PubMed     Abstract available

  90. FLETCHER A, Forbes A, Svenson N, Wayne Thomas D, et al
    Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children.
    Br J Haematol. 2022;196:523-529.

  91. POPLAWSKA M, Dutta D, Jayaram M, Salifu M, et al
    Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease.
    Br J Haematol. 2022;196:777-780.
    PubMed     Abstract available

  92. GERRITSMA J, Bongaerts V, Eckhardt C, Heijboer H, et al
    Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Br J Haematol. 2022;196:769-776.
    PubMed     Abstract available

  93. BARADE A, Aboobacker F, Korula A, Lakshmi K, et al
    Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia.
    Br J Haematol. 2022;196:724-734.
    PubMed     Abstract available

  94. MAGGIO A
    Cell erythroid maturation approach: a new paradigm in the road map towards a cure for beta-thalassaemia syndromes.
    Br J Haematol. 2022;196:806-808.

  95. OAKLEY LL, Mitchell S, von Rege I, Hadebe R, et al
    Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK.
    Br J Haematol. 2022;196:1069-1075.
    PubMed     Abstract available

  96. VLACHODIMITROPOULOU E, Garbowski M, Anne Solomon S, Abbasi N, et al
    Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
    Br J Haematol. 2022;196:1096-1104.
    PubMed     Abstract available

  97. JONASSAINT CR, Lukombo I, Feldman R, Driscoll J, et al
    Differences in the prevalence of mental health disorders among Black American adults with sickle cell disease compared to those with non-heritable medical conditions or no medical conditions.
    Br J Haematol. 2022;196:1059-1068.
    PubMed     Abstract available

  98. WHITE J, Callaghan MU, Gao X, Liu K, et al
    Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease.
    Br J Haematol. 2022;196:1052-1058.
    PubMed     Abstract available

  99. TANEJA K, Verma C, Mahajan A
    Can ruxolitinib avert splenectomy in patients with thalassaemia: a short term case series.
    Br J Haematol. 2022;196:1111-1113.

  100. VENUGOPAL J, Wang J, Guo C, Eitzman DT, et al
    Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling.
    Br J Haematol. 2022;196:1040-1051.
    PubMed     Abstract available

    January 2022
  101. NAVILLE AS, Lazaro E, Boutin J, Prot-Leurent C, et al
    Acquired glucose 6-phosphate dehydrogenase (G6PD) deficiency in a patient with Chronic Myelomonocytic Leukemia.
    Br J Haematol. 2022 Jan 6. doi: 10.1111/bjh.18037.

  102. BRODSKY RA, Lee JW, Nishimura JI, Szer J, et al
    Lactate dehydrogenase versus haemoglobin: which one is the better marker in paroxysmal nocturnal haemoglobinuria?
    Br J Haematol. 2022;196:264-265.

  103. RUND D
    A Paradigm shift in genotype-phenotype relationships in beta-thalassaemia.
    Br J Haematol. 2022;196:270-271.

  104. ROY NBA
    Iron overload in inherited anaemias: why one size can't fit all.
    Br J Haematol. 2022;196:266-267.

  105. SMITH WR, McClish DK, Lottenberg R, Sisler IY, et al
    A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
    Br J Haematol. 2022;196:193-203.
    PubMed     Abstract available

  106. CHAPIN J, Cohen AR, Neufeld EJ, Vichinsky E, et al
    An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
    Br J Haematol. 2022;196:380-389.
    PubMed     Abstract available

  107. MUSALLAM KM, Vitrano A, Meloni A, Addario Pollina S, et al
    Primary HBB gene mutation severity and long-term outcomes in a global cohort of beta-thalassaemia.
    Br J Haematol. 2022;196:414-423.
    PubMed     Abstract available

  108. SHAH FT, Porter JB, Sadasivam N, Kaya B, et al
    Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
    Br J Haematol. 2022;196:336-350.

  109. CHEN N, Li Z, Huang Y, Xiao C, et al
    Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during pregnan
    Br J Haematol. 2022;196:390-396.
    PubMed     Abstract available

  110. KIENZLE SL, Rodeghier M, Liem RI
    Heart rate variability associated with acute exercise challenge in children with sickle cell anaemia.
    Br J Haematol. 2022;196:397-401.
    PubMed     Abstract available

  111. ADEBAYO OC, Betukumesu DK, Nkoy AB, Adesoji OM, et al
    Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia.
    Br J Haematol. 2022;196:204-214.
    PubMed     Abstract available

  112. GRIFFIN R, Panayiotou A, Allen P, Height S, et al
    What is the role of chest X-ray imaging in the acute management of children with sickle cell disease?
    Br J Haematol. 2022;196:402-413.
    PubMed     Abstract available

  113. COLMAN KS, Pavord S, Roy N
    A quality improvement project for the cost-effective management of maternal anaemia.
    Br J Haematol. 2022;196:445-448.

  114. VASSEUR C, Domingues-Hamdi E, Pakdaman S, Galacteros F, et al
    Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment.
    Br J Haematol. 2022;196:183-192.
    PubMed     Abstract available

  115. RISITANO AM, Peffault de Latour R
    How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.
    Br J Haematol. 2022;196:288-303.
    PubMed     Abstract available

  116. DEXTER D, McGann PT
    Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Br J Haematol. 2022;196:63-69.
    PubMed     Abstract available

  117. MANABE M, Hagiwara Y, Asada R, Tanizawa N, et al
    Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole-arm translocation, der(14;20)(q10;p10).
    Br J Haematol. 2022;196:7.

  118. BARRITEAU CM, Chiu A, Rodeghier M, Liem RI, et al
    Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemia.
    Br J Haematol. 2022;196:179-182.
    PubMed     Abstract available

  119. HUGHES AD, Kurre P
    The impact of clonal diversity and mosaicism on haematopoietic function in Fanconi anaemia.
    Br J Haematol. 2022;196:274-287.
    PubMed     Abstract available

  120. GABELLI M, Ademokun C, Cooper N, Amrolia PI, et al
    Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting.
    Br J Haematol. 2022;196:45-62.
    PubMed     Abstract available

    December 2021
  121. AOUN SA, Motabi I
    Cold agglutinin disease after COVID-19 vaccine.
    Br J Haematol. 2021;195:650.

  122. LIN J, Ye Y, Shang X, Zhang Y, et al
    TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the gamma-globin gene promoters.
    Br J Haematol. 2021;195:764-769.
    PubMed     Abstract available

  123. NAKAGAWA N, Ishiyama K, Tanabe M, Yoroidaka T, et al
    The effectiveness of immunosuppressive therapy in patients with aplastic anaemia secondary to chemoradiotherapy for cancers.
    Br J Haematol. 2021;195:770-780.
    PubMed     Abstract available

  124. BADAWY SM, Payne AB, Hulihan MM, Coates TD, et al
    Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Cont
    Br J Haematol. 2021;195:e160-e164.

  125. WILSON SR, Sears M, Williams E, Drapekin J, et al
    Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Br J Haematol. 2021;195:e157-e160.

    November 2021
  126. HALL R, Meenan J, Mihalca D, Katumba A, et al
    The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey.
    Br J Haematol. 2021;195:532-535.

  127. LILES DK, Shah NR, Scullin B, Gordeuk VR, et al
    Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
    Br J Haematol. 2021;195:e150-e153.

  128. EL-AMIN N, Lauzon SD, Nietert PJ, Kanter J, et al
    Which adults with sickle cell disease need an evaluation for pulmonary embolism?
    Br J Haematol. 2021;195:447-455.
    PubMed     Abstract available

  129. WANG W, Freeman M, Hamilton L, Carroll Y, et al
    Developmental screening of three-year-old children with sickle cell disease compared to controls.
    Br J Haematol. 2021;195:621-628.
    PubMed     Abstract available

  130. BOISSON C, Renoux C, Nader E, Gauthier A, et al
    Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without alpha-thalassaemia.
    Br J Haematol. 2021;195:629-633.
    PubMed     Abstract available

  131. LAFAURIE M, Maquet J, Baricault B, Ekstrand C, et al
    Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Br J Haematol. 2021;195:456-465.
    PubMed     Abstract available

  132. RANKINE-MULLINGS A, Reid M, Soares D, Taylor-Bryan C, et al
    Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
    Br J Haematol. 2021;195:612-620.
    PubMed     Abstract available

  133. BALLAS SK, Kuypers FA, Gordeuk VR, Hankins JS, et al
    Time to rethink haemoglobin threshold guidelines in sickle cell disease.
    Br J Haematol. 2021;195:518-522.
    PubMed     Abstract available

    October 2021
  134. HE Z, Sun X, Wang S, Bai D, et al
    Ggct (gamma-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival.
    Br J Haematol. 2021;195:267-275.
    PubMed     Abstract available

    Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease.
    Br J Haematol. 2021;195:158-159.

  136. CAPPELLI B, Scigliuolo GM, Boukouaci W, Rafii H, et al
    Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease.
    Br J Haematol. 2021;195:e128-e131.

  137. HEITZER AM, Longoria J, Okhomina V, Wang WC, et al
    Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.
    Br J Haematol. 2021;195:256-266.
    PubMed     Abstract available

  138. DEREBAIL VK, Zhou Q, Ciccone EJ, Cai J, et al
    Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease.
    Br J Haematol. 2021;195:123-132.
    PubMed     Abstract available

    September 2021
  139. MASLAH N, Ravdan O, Drevon L, Verger E, et al
    Revisiting Diagnostic performances of serum erythropoietin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
    Br J Haematol. 2021 Sep 25. doi: 10.1111/bjh.17848.
    PubMed     Abstract available

  140. BARCELLINI W, Fattizzo B, Giannotta JA, Quattrocchi L, et al
    COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey.
    Br J Haematol. 2021;194:854-856.

  141. MUNARETTO V, Voi V, Palazzi G, Notarangelo LD, et al
    Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.
    Br J Haematol. 2021;194:851-854.

  142. HINES PC, Callaghan MU, Zaidi AU, Gao X, et al
    Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease.
    Br J Haematol. 2021;194:1074-1082.
    PubMed     Abstract available

  143. OTENG-NTIM E, Pavord S, Howard R, Robinson S, et al
    Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline.
    Br J Haematol. 2021;194:980-995.

    Standardizing care of those at great risk: the importance of sickle cell in pregnancy practice guidelines.
    Br J Haematol. 2021;194:950-953.

  145. GAARTMAN AE, Sayedi AK, Gerritsma JJ, de Back TR, et al
    Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.
    Br J Haematol. 2021;194:899-907.
    PubMed     Abstract available

  146. PECKER LH, Sharma D, Nero A, Paidas MJ, et al
    Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.
    Br J Haematol. 2021;194:970-979.
    PubMed     Abstract available

  147. RIEGER MJ, Stolz SM, Ludwig S, Benoit TM, et al
    Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.
    Br J Haematol. 2021;194:931-934.

  148. BOUDHABHAY I, Boutin E, Bartolucci P, Bornes MI, et al
    Impact of pre-eclampsia on renal outcome in sickle cell disease patients.
    Br J Haematol. 2021;194:1053-1062.
    PubMed     Abstract available

  149. MALINOWSKI AK, Kuo KHM, Tomlinson GA, Palcu P, et al
    Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data.
    Br J Haematol. 2021;194:1063-1073.
    PubMed     Abstract available

  150. SARAF SL
    The vasculopathic cord between pre-eclampsia and kidney function in sickle cell disease.
    Br J Haematol. 2021;194:947-949.

  151. KUMKHAEK C, Uchida N, Tisdale JF, Rodgers GP, et al
    Comparison of CD34(+) cells isolated from frozen cord blood and fresh adult peripheral blood of sickle cell disease patients in gene correction of the sickle mutation at late-stage erythroid differentiation.
    Br J Haematol. 2021;194:e80-e84.

  152. GOTTGENS EL, Ligthart PC, Veldhuisen B, Veldthuis M, et al
    Rh-null phenotype and stomatocytosis.
    Br J Haematol. 2021;194:803.

    Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries.
    Br J Haematol. 2021;194:954-969.
    PubMed     Abstract available

    August 2021
  154. NJOKU F, Zhang X, Shah BN, Machado RF, et al
    Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study.
    Br J Haematol. 2021;194:767-778.
    PubMed     Abstract available

  155. ELSHERIF L, Scott LC, Wichlan D, Jones SK, et al
    Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study.
    Br J Haematol. 2021;194:e71-e73.

  156. QUINN CT, Niss O, Dong M, Pfeiffer A, et al
    Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.
    Br J Haematol. 2021;194:617-625.
    PubMed     Abstract available

  157. TANGSRICHAROEN T, Natesirinilkul R, Phusua A, Fanhchaksai K, et al
    Severe neonatal haemolytic anaemia caused by compound heterozygous KLF1 mutations: report of four families and literature review.
    Br J Haematol. 2021;194:626-634.
    PubMed     Abstract available

    July 2021
  158. FATTIZZO B, Rizzo L, Giannotta JA, Mazzon F, et al
    Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
    Br J Haematol. 2021 Jul 26. doi: 10.1111/bjh.17722.

  159. KILLICK SB, Ingram W, Culligan D, Enright H, et al
    British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
    Br J Haematol. 2021;194:267-281.

  160. MITTELMAN M, Oster HS
    Thrombocytopenia in myelodysplastic syndromes: time to lift the embargo on thrombomimetics?
    Br J Haematol. 2021;194:231-233.

  161. RASHKIN SR, Rampersaud E, Kang G, Ataga KI, et al
    Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results.
    Br J Haematol. 2021;194:469-473.
    PubMed     Abstract available

  162. ESTEPP JH, Cong Z, Agodoa I, Kang G, et al
    What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
    Br J Haematol. 2021;194:463-468.
    PubMed     Abstract available

  163. ALNAFIE AN, Alateeq SA, Al-Muhanna FA, Alsulaiman AM, et al
    Exome sequencing in high and low fetal haemoglobin Arab-Indian haplotype sickle cell disease.
    Br J Haematol. 2021;194:e61-e64.

  164. PERES L, Monedero Alonso D, Nudel M, Figeac M, et al
    Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype.
    Br J Haematol. 2021;194:e51-e55.

  165. VADOLAS J, Ng GZ, Kysenius K, Crouch PJ, et al
    SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of beta-thalassaemia.
    Br J Haematol. 2021;194:200-210.
    PubMed     Abstract available

  166. TAHER AT, Viprakasit V, Cappellini MD, Kraus D, et al
    Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent beta-thalassaemia.
    Br J Haematol. 2021;194:474-477.

  167. WICKRAMASINGHE W, Dissanayake R, Raj R, Gooneratne L, et al
    The first report of allogeneic haematopoietic stem cell transplantations for bone marrow failure performed in Sri Lanka.
    Br J Haematol. 2021;194:e56-e58.

  168. TAMAGNE M, Pakdaman S, Bartolucci P, Habibi A, et al
    Whole-blood CCR7 expression and chemoattraction in red blood cell alloimmunization.
    Br J Haematol. 2021;194:477-481.

  169. RIEU JB, El Kassir A, Largeaud L, Dion J, et al
    Characteristic vacuolisation of granulocytic and erythroid precursors associated with VEXAS syndrome.
    Br J Haematol. 2021;194:8.

  170. WARE RE, Dertinger SD
    Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia.
    Br J Haematol. 2021;194:252-266.
    PubMed     Abstract available

  171. PACE BS, Starlard-Davenport A, Kutlar A
    Sickle cell disease: progress towards combination drug therapy.
    Br J Haematol. 2021;194:240-251.
    PubMed     Abstract available

    June 2021
  172. PATON C, Mathews L, Groarke EM, Rios O, et al
    COVID-19 infection in patients with severe aplastic anaemia.
    Br J Haematol. 2021;193:902-905.

  173. HANDS K, Taylor C, Kotze A, Richards T, et al
    Preoperative patient blood management during the SARS-CoV-2 pandemic.
    Br J Haematol. 2021;193:1087-1092.

    HbA2 induction: the merit of pancellularity in sickle cell disease.
    Br J Haematol. 2021;193:1032-1033.

  175. HILLS RK
    Diagnosing Diamond-Blackfan anaemia: 'Vorsprung durch Technik'.
    Br J Haematol. 2021;193:1030-1031.

  176. BLAISE D, Savani BN
    Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?
    Br J Haematol. 2021;193:863-864.

  177. PORCU S, Simbula M, Marongiu MF, Perra A, et al
    Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
    Br J Haematol. 2021;193:1228-1237.
    PubMed     Abstract available

  178. VAN DOOIJEWEERT B, Broeks MH, van Beers EJ, Verhoeven-Duif NM, et al
    Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia.
    Br J Haematol. 2021;193:1185-1193.
    PubMed     Abstract available

  179. LIANG Y, Zhang X, Liu Y, Wang L, et al
    GATA zinc finger domain-containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with beta-thalassaemia through impaired formation of methyl-binding domain protein 2 (MBD2)-containing nucleosome remodelling and deacetylatio
    Br J Haematol. 2021;193:1220-1227.
    PubMed     Abstract available

  180. CHILDS RW, Tian X, Vo P, Purev E, et al
    Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Br J Haematol. 2021;193:951-960.
    PubMed     Abstract available

  181. MAITLAND K, Kiguli S, Olupot-Olupot P, Opoka RO, et al
    Transfusion management of severe anaemia in African children: a consensus algorithm.
    Br J Haematol. 2021;193:1247-1259.
    PubMed     Abstract available

  182. LAAS C, Lambert C, Senior McKenzie T, Sheldon E, et al
    Improving the laboratory diagnosis of pyruvate kinase deficiency.
    Br J Haematol. 2021;193:994-1000.
    PubMed     Abstract available

  183. JANG T, Mo G, Stewart C, Egini O, et al
    Antibiotic use in adults during sickle cell vaso-occlusive crisis: Is it time for a controlled trial?
    Br J Haematol. 2021;193:1281-1283.

  184. MARTINO S, Arlet JB, Odievre MH, Jullien V, et al
    Deficient mitophagy pathways in sickle cell disease.
    Br J Haematol. 2021;193:988-993.
    PubMed     Abstract available

  185. XU Y, Alfaro-Magallanes VM, Babitt JL
    Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
    Br J Haematol. 2021;193:882-893.
    PubMed     Abstract available

  186. JUNG M, Mehta PA, Jiang CS, Rosti RO, et al
    Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia.
    Br J Haematol. 2021;193:971-975.
    PubMed     Abstract available

    May 2021
  187. UYOGA S, George EC, Bates I, Olupot-Olupot P, et al
    Point-of-care haemoglobin testing in African hospitals: a neglected essential diagnostic test.
    Br J Haematol. 2021 May 15. doi: 10.1111/bjh.17431.
    PubMed     Abstract available

  188. BARCELLINI W, Colombatti R
    The impact of Parvovirus B19 on hereditary haemolytic anaemias.
    Br J Haematol. 2021;193:703-704.

  189. BOOTH GS, Savani BN, Langston AA
    Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation.
    Br J Haematol. 2021;193:701-702.

  190. ELBADRY MI, Khaled SAA, Ahmed NM, Abudeif A, et al
    Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological st
    Br J Haematol. 2021;193:827-840.
    PubMed     Abstract available

  191. LONGVAL T, Galimard JE, Lepretre AC, Suarez F, et al
    Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
    Br J Haematol. 2021;193:814-826.
    PubMed     Abstract available

  192. VINCHI F, Sparla R, Passos ST, Sharma R, et al
    Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.
    Br J Haematol. 2021;193:637-658.
    PubMed     Abstract available

  193. RUND D
    Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?
    Br J Haematol. 2021;193:466-480.
    PubMed     Abstract available

  194. SARAF SL, Zhang X, Shah BN, Raslan R, et al
    Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy.
    Br J Haematol. 2021;193:628-632.
    PubMed     Abstract available

  195. DENTON CC, Detterich JA, Coates TD, Wood JC, et al
    Kidney iron deposition by R2* is associated with haemolysis and urinary iron.
    Br J Haematol. 2021;193:633-636.
    PubMed     Abstract available

    April 2021
  196. BERNARD F, Uppungunduri CRS, Meyer S, Cummins M, et al
    Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
    Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17418.
    PubMed     Abstract available

  197. CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
    COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
    Br J Haematol. 2021;193:43-51.

  198. BENNETT R, Ruskova A
    Atezolizumab-induced pure red cell aplasia.
    Br J Haematol. 2021;193:10.

  199. LADU AI, Aiyenigba AO, Adekile A, Bates I, et al
    The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review.
    Br J Haematol. 2021;193:26-42.
    PubMed     Abstract available

  200. SHAFIEE S, Gelebart P, Popa M, Hellesoy M, et al
    Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.
    Br J Haematol. 2021;193:415-419.

  201. CHENG Y, Shang X, Chen D, Pang D, et al
    MicroRNA-2355-5p regulates gamma-globin expression in human erythroid cells by inhibiting KLF6.
    Br J Haematol. 2021;193:401-405.
    PubMed     Abstract available

  202. QUINTINO DE OLIVEIRA B, Catto LFB, Santana BAA, Tellechea MF, et al
    Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
    Br J Haematol. 2021;193:410-414.
    PubMed     Abstract available

    March 2021
  203. SAULSBERRY-ABATE AC, Partanen M, Porter JS, Podila PSB, et al
    Cognitive performance as a predictor of healthcare transition in sickle cell disease.
    Br J Haematol. 2021;192:1082-1091.
    PubMed     Abstract available

  204. AL-SAMKARI H, Addonizio K, Glader B, Morton DH, et al
    The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Br J Haematol. 2021;192:1092-1096.
    PubMed     Abstract available

  205. EGOT M, Lasne D, Poirault-Chassac S, Mirault T, et al
    Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
    Br J Haematol. 2021;192:909-921.
    PubMed     Abstract available

  206. ATAGA KI, Staffa SJ, Brugnara C, Stocker JW, et al
    Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
    Br J Haematol. 2021;192:e129-e132.

  207. OIKONOMOPOULOU C, Paisiou A, Komitopoulou A, Ioannidou ED, et al
    Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with beta-thalassaemia.
    Br J Haematol. 2021;192:e127-e129.

  208. SACHDEV V, Tian X, Gu Y, Nichols J, et al
    A phenotypic risk score for predicting mortality in sickle cell disease.
    Br J Haematol. 2021;192:932-941.
    PubMed     Abstract available

  209. RIBEIRO PR, Teixeira RDS, Souza AR, Pereira TCS, et al
    Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Br J Haematol. 2021;192:922-931.
    PubMed     Abstract available

    February 2021
  210. CAIRO MS, Savani BN
    Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
    Br J Haematol. 2021;192:678-680.

  211. OLSON TS
    Paediatric severe aplastic anaemia treatment: where to start?
    Br J Haematol. 2021;192:417-419.

  212. ALZAHRANI M, Damlaj M, Jeffries N, Alahmari B, et al
    Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
    Br J Haematol. 2021;192:761-768.
    PubMed     Abstract available

  213. YUAN S, Jordan LC, Davis LT, Cogswell PM, et al
    A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.
    Br J Haematol. 2021;192:769-777.
    PubMed     Abstract available

  214. GROARKE EM, Patel BA, Gutierrez-Rodrigues F, Rios O, et al
    Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia.
    Br J Haematol. 2021;192:605-614.
    PubMed     Abstract available

  215. HOTINSKI AK, Best OG, Thurgood LA, Lower KM, et al
    A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
    Br J Haematol. 2021;192:e77-e81.

  216. DEMBELE AK, Lapoumeroulie C, Diaw M, Tessougue O, et al
    Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
    Br J Haematol. 2021;192:634-642.
    PubMed     Abstract available

  217. VITRANO A, Meloni A, Addario Pollina W, Karimi M, et al
    A complication risk score to evaluate clinical severity of thalassaemia syndromes.
    Br J Haematol. 2021;192:626-633.
    PubMed     Abstract available

  218. CASTLEMAN JS, Moise KJ Jr, Kilby MD
    Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
    Br J Haematol. 2021;192:425-432.
    PubMed     Abstract available

    January 2021
    Romiplostim in aplastic anaemia - another tool in the armamentarium.
    Br J Haematol. 2021;192:15-16.

  220. MINGOIA M, Caria CA, Ye L, Asunis I, et al
    Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells.
    Br J Haematol. 2021;192:395-404.
    PubMed     Abstract available

  221. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience.
    Br J Haematol. 2021;192:e54-e57.

  222. SHARMA POUDYAL B, Gyawali B, Rondelli D
    The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.
    Br J Haematol. 2021;192:e63-e65.

  223. GREGOIRE-PELCHAT P, Pastore Y, Robitaille N, LeMay S, et al
    Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
    Br J Haematol. 2021;192:385-394.
    PubMed     Abstract available

  224. PATEL A, Gan K, Li AA, Weiss J, et al
    Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease.
    Br J Haematol. 2021;192:158-170.
    PubMed     Abstract available

  225. JANG JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al
    Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
    Br J Haematol. 2021;192:190-199.
    PubMed     Abstract available

  226. CHAN LKL, Mak VWM, Chan SCH, Yu ELM, et al
    Liver complications of haemoglobin H disease in adults.
    Br J Haematol. 2021;192:171-178.
    PubMed     Abstract available

  227. MTENGA J, Orf K, Zheng J, Chamba C, et al
    Haematopoietic stem cell transplantation in Tanzania.
    Br J Haematol. 2021;192:17-21.

  228. SPEICH C, Wegmuller R, Brittenham GM, Zeder C, et al
    Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe).
    Br J Haematol. 2021;192:179-189.
    PubMed     Abstract available

  229. MANARA R, Dalla Torre A, Lucchetta M, Ermani M, et al
    Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study.
    Br J Haematol. 2021;192:151-157.
    PubMed     Abstract available

    December 2020
  230. RUND D
    The evolution of clinical research in thalassaemia: where has all the funding gone?
    Br J Haematol. 2020;191:666-667.

  231. JOBANPUTRA M, Paramore C, Laird SG, McGahan M, et al
    Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
    Br J Haematol. 2020;191:897-905.
    PubMed     Abstract available

  232. URIO F, Nkya S, Rooks H, Mgaya JA, et al
    F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
    Br J Haematol. 2020;191:888-896.
    PubMed     Abstract available

  233. FORTE S, Eng B, Verhovsek M, Soulieres D, et al
    Microcytosis in patients with haemoglobin C trait: is alpha-thalassaemia trait to blame?
    Br J Haematol. 2020;191:e129-e131.

  234. TANG D, Liu S, Sun H, Qin X, et al
    All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
    Br J Haematol. 2020;191:906-919.
    PubMed     Abstract available

  235. PECKER LH, Hussain S, Christianson MS, Lanzkron S, et al
    Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
    Br J Haematol. 2020;191:880-887.
    PubMed     Abstract available

  236. VALI S, Mukhtar S, Nandi A, Wilson K, et al
    Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review.
    Br J Haematol. 2020;191:875-879.
    PubMed     Abstract available

    November 2020
  237. VERLHAC S, Gabor F, Paillard C, Chateil JF, et al
    Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
    Br J Haematol. 2020 Nov 20. doi: 10.1111/bjh.17178.
    PubMed     Abstract available

  238. WEI Z, Yang G, Huang Y, Peng P, et al
    A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.
    Br J Haematol. 2020;191:e81-e83.

  239. PEZINA-CANTU C, Gomez-De Leon A, Jaime-Perez JC, Colunga-Pedraza P, et al
    Pernicious anaemia can be treated effectively with a single high dose of cobalamin.
    Br J Haematol. 2020;191:e97-e100.

  240. SIRIWORADETKUN S, Thubthed R, Thiengtavor C, Paiboonsukwong K, et al
    Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised beta-thalassaemia/HbE patients.
    Br J Haematol. 2020;191:e72-e76.

  241. HAN J, Holden CC, Ahluwalia AY, Molokie RE, et al
    Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease.
    Br J Haematol. 2020;191:e70-e72.

  242. PEFFAULT DE LATOUR R, Brodsky RA, Ortiz S, Risitano AM, et al
    Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
    Br J Haematol. 2020;191:476-485.
    PubMed     Abstract available

  243. TOLE S, Dhir P, Pugi J, Drury LJ, et al
    Genotype-phenotype correlation in children with hereditary spherocytosis.
    Br J Haematol. 2020;191:486-496.
    PubMed     Abstract available

    October 2020
  244. HERISHANU Y, Levi S, Kamdjou T, Bornstein Y, et al
    Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2020 Oct 23. doi: 10.1111/bjh.17105.

  245. SHEHA D, El-Shayeb M, Eid Y, Amin M, et al
    Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.
    Br J Haematol. 2020;191:e38-e40.

  246. PIKE A, Muus P, Munir T, Mitchell L, et al
    COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
    Br J Haematol. 2020;191:e1-e4.

  247. ROIZENBLATT S, Cabanas-Pedro AC, Figueiredo MS
    Rheumatoid arthritis and sickle cell disease: A potential association.
    Br J Haematol. 2020;191:e25-e28.

  248. BARGEHR C, Crazzolara R
    Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome.
    Br J Haematol. 2020;191:11.

  249. TEOFILI L, Papacci P, Orlando N, Bianchi M, et al
    Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.
    Br J Haematol. 2020;191:263-268.
    PubMed     Abstract available

  250. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
    Br J Haematol. 2020;191:107-114.
    PubMed     Abstract available

    September 2020
  251. NESR G, Koshy R, Foldes D, Kagdi H, et al
    Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naive chronic lymphocytic leukaemia: a case report.
    Br J Haematol. 2020;190:e326-e328.

    Poverty and severity of childhood sickle cell disease.
    Br J Haematol. 2020;190:819-821.

  253. WOUTERS HJCM, Stam SP, van der Klauw MM, Bakker SJL, et al
    The association between haemoglobin concentrations and muscle mass determined from urinary creatinine excretion rate: a population-based cohort study.
    Br J Haematol. 2020;190:e349-e352.

  254. GERARD D, Bourin S, Phulpin A, Picard V, et al
    Previously misdiagnosed red cell membrane disorder and familial consequences.
    Br J Haematol. 2020;190:810.

  255. LIAPIS K, Vrachiolias G, Spanoudakis E, Kotsianidis I, et al
    Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
    Br J Haematol. 2020;190:809.

  256. MCGINNIS E, Smith TW
    Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions.
    Br J Haematol. 2020;190:641.

  257. DE SANTIS GC, Costa TCM, Santos FLS, da Silva-Pinto AC, et al
    Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience.
    Br J Haematol. 2020;190:e295-e297.

  258. BELLO-MANGA H, Galadanci AA, Abdullahi S, Ali S, et al
    Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
    Br J Haematol. 2020;190:939-944.
    PubMed     Abstract available

    August 2020
  259. APPIAH-KUBI A, Acharya S, Fein Levy C, Vlachos A, et al
    Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
    Br J Haematol. 2020;190:e221-e224.

    Regulatory cells in immune-mediated aplastic anaemia - not Tregs but Bregs.
    Br J Haematol. 2020;190:486-487.

  261. GIBSON JS
    A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
    Br J Haematol. 2020;190:488-489.

  262. COLOMBATTI R, Andemariam B
    Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools.
    Br J Haematol. 2020;190:309-310.

    Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?
    Br J Haematol. 2020;190:306-308.

  264. MOURA PL, Dobbe JGG, Streekstra GJ, Rab MAE, et al
    Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning.
    Br J Haematol. 2020;190:e250-e255.

  265. ANDREWS C, Maze D, Murphy T, Sibai H, et al
    Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
    Br J Haematol. 2020;190:467-470.

  266. FILIPPIDOU M, Avgerinou G, Tsipou H, Tourkantoni N, et al
    Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Br J Haematol. 2020;190:e157-e159.

  267. FUNG EB, Ahmad T, Killilea DW, Hussain R, et al
    Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
    Br J Haematol. 2020;190:e162-e166.

  268. LUEWAN S, Charoenkwan P, Sirichotiyakul S, Tongsong T, et al
    Fetal haemoglobin H-Constant Spring disease: a role for intrauterine management.
    Br J Haematol. 2020;190:e233-e236.

  269. NOOMUNA P, Risinger M, Zhou S, Seu K, et al
    Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Br J Haematol. 2020;190:599-609.
    PubMed     Abstract available

  270. TIMMERMANS SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, et al
    The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.
    Br J Haematol. 2020;190:442-449.
    PubMed     Abstract available

  271. ZAIMOKU Y, Patel BA, Kajigaya S, Feng X, et al
    Deficit of circulating CD19(+) CD24(hi) CD38(hi) regulatory B cells in severe aplastic anaemia.
    Br J Haematol. 2020;190:610-617.
    PubMed     Abstract available

  272. SAMARRON SL, Miller JW, Cheung AT, Chen PC, et al
    Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.
    Br J Haematol. 2020;190:450-457.
    PubMed     Abstract available

  273. WILSON S, Ellsworth P, Key NS
    Pregnancy in sickle cell trait: what we do and don't know.
    Br J Haematol. 2020;190:328-335.
    PubMed     Abstract available

    July 2020
  274. CHAKRAVORTY S, Rees D
    Commentary on sickle cell non-invasive prenatal testing article.
    Br J Haematol. 2020;190:20-21.

  275. JEREBTSOVA M, Taye A, Smith N, Afangbedji N, et al
    Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
    Br J Haematol. 2020;190:e45-e48.

  276. PEDROSA AM, Lemes RPG
    Gene expression of HIF-1alpha and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
    Br J Haematol. 2020;190:e39-e42.
    PubMed     Abstract available

  277. NARDO-MARINO A, Brousse V, Rees D
    Emerging therapies in sickle cell disease.
    Br J Haematol. 2020;190:149-172.
    PubMed     Abstract available

    Diamond-Blackfan anaemia: understanding an old disease.
    Br J Haematol. 2020;190:14-15.

  279. VAN CAMPEN J, Silcock L, Yau S, Daniel Y, et al
    A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.
    Br J Haematol. 2020;190:119-124.
    PubMed     Abstract available

  280. QUARELLO P, Garelli E, Carando A, Cillario R, et al
    A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?
    Br J Haematol. 2020;190:93-104.
    PubMed     Abstract available

    June 2020
    PNH phenotypes and their genesis.
    Br J Haematol. 2020;189:802-805.

  282. HYACINTH HI, Idris IM
    Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
    Br J Haematol. 2020;189:1014-1015.

  283. GIRELLI D, Busti F
    ERFE regulation in sickle cell disease: complex but promising.
    Br J Haematol. 2020;189:1012-1013.

  284. KHAMPHIKHAM P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, et al
    High-level induction of fetal haemoglobin by pomalidomide in beta-thalassaemia/HbE erythroid progenitor cells.
    Br J Haematol. 2020;189:e240-e245.

  285. BREWIN JN, Crowley MP, Kesse-Adu R, Stuart-Smith S, et al
    Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
    Br J Haematol. 2020;189:e198-e200.

  286. PARTANEN M, Kang G, Wang WC, Krull K, et al
    Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Br J Haematol. 2020;189:1192-1203.
    PubMed     Abstract available

  287. RICHARDS SJ, Dickinson AJ, Cullen MJ, Griffin M, et al
    Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Br J Haematol. 2020;189:954-966.
    PubMed     Abstract available

  288. PRATS-MARTIN C, Mezquita L, Garcia-Canale S, Jimenez-Jambrina M, et al
    Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
    Br J Haematol. 2020;189:800.

  289. MANGAONKAR AA, Thawer F, Son J, Ajebo G, et al
    Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Br J Haematol. 2020;189:1204-1209.
    PubMed     Abstract available

  290. AL-ALI HK, Griesshammer M, Foltz L, Palumbo GA, et al
    Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
    Br J Haematol. 2020;189:888-903.
    PubMed     Abstract available

  291. PATEL BJ, Barot SV, Kuzmanovic T, Kerr C, et al
    Distinctive and common features of moderate aplastic anaemia.
    Br J Haematol. 2020;189:967-975.
    PubMed     Abstract available

    May 2020
  292. ANTELO G, Mangaonkar AA, Coltro G, Buradkar A, et al
    Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Br J Haematol. 2020;189:e104-e108.

  293. SHAH BN, Hassan TO, Zhang X, McClain DA, et al
    Increased iron stores influence glucose metabolism in sickle cell anaemia.
    Br J Haematol. 2020;189:e184-e187.

  294. SKINNER S, Ling Liu K, Lo M, Josset-Lamaugarny A, et al
    Alterations in vascular reactivity in a transgenic mouse model of sickle cell trait.
    Br J Haematol. 2020;189:e154-e157.

  295. GOUVEIA C, Duarte M, Norte S, Alves P, et al
    Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria.
    Br J Haematol. 2020;189:e147-e150.

  296. PHILIP KEJ, Sadaka AS, Polkey MI, Hopkinson NS, et al
    The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.
    Br J Haematol. 2020;189:566-572.
    PubMed     Abstract available

  297. LEONARD A, Tisdale J, Abraham A
    Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Br J Haematol. 2020;189:408-423.
    PubMed     Abstract available

  298. MCCORMICK M, Richardson T, Warady BA, Novelli EM, et al
    Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
    Br J Haematol. 2020;189:559-565.
    PubMed     Abstract available

    April 2020
  299. ALI JS, Andrasik F, Berlin KS, Porter J, et al
    Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease.
    Br J Haematol. 2020;189:e27-e30.

  300. FAYAND A, Dzierzynski N, Georgin-Lavialle S, Bachmeyer C, et al
    The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle-cell patients: a cohort study.
    Br J Haematol. 2020;189:e21-e23.

  301. ROPER D, Layton M, Rees D, Lambert C, et al
    Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
    Br J Haematol. 2020;189:24-38.

  302. THIENGTAVOR C, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, et al
    Increased ferritin levels in non-transfusion-dependent beta degrees -thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration.
    Br J Haematol. 2020;189:187-198.
    PubMed     Abstract available

  303. FUJISAWA M, Yasumoto A, Kato H, Sugawara Y, et al
    The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
    Br J Haematol. 2020;189:182-186.
    PubMed     Abstract available

  304. NICKEL RS, Horan JT, Abraham A, Qayed M, et al
    Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Br J Haematol. 2020;189:162-170.
    PubMed     Abstract available

  305. QUARTA A, Sgherza N, Pasanisi A, Solfrizzi MP, et al
    Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
    Br J Haematol. 2020;189:e60-e63.

    March 2020
  306. AUERBACH M, Georgieff MK
    Guidelines for iron deficiency in pregnancy: hope abounds: Commentary to accompany: UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:814-816.

  307. AGGARWAL A, Jamwal M, Sharma P, Sachdeva MUS, et al
    Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
    Br J Haematol. 2020;188:784-795.
    PubMed     Abstract available

  308. HANSEN S, Wood DK, Higgins JM
    5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
    Br J Haematol. 2020;188:985-993.
    PubMed     Abstract available

  309. CORNELISSE AC, Bergkamp FJM, Griffioen-Keijzer A
    Haemolytic anaemia: an unrecognised side effect of hydroxyurea?
    Br J Haematol. 2020;188:e80-e81.

  310. STALLINGS AM, Majhail NS, Nowacki AS, Onimoe GI, et al
    Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
    Br J Haematol. 2020;188:976-984.
    PubMed     Abstract available

  311. PAVORD S, Daru J, Prasannan N, Robinson S, et al
    UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:819-830.

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.